year
Jiangsu Realpharma Technology Co., Ltd. Based on the unique advantages ofβ-lactamase inhibitor API and intermediates production base, who has abundant experience for the reactions like Azidation, metal catalysis, Chlorination, deep cool, ultra-temperature, Ammonification etc., we develop Antiviral, Cardiovascular, Anti-obesity and other fields of characteristic intermediate, API and drugs, and provide high added value and cost-effective products to our domestic and overseas customers. At the same time, we possess the leading core technologies on continuous flow micro-reaction, asymmetric synthesis, enzyme catalysis and others. We support and deeply participate in R&D of generic and innovative drugs with high clinical value and core technology, aim at a quick launch of drugs. Realshare keep the strategy of both internal development and external expand: focus on research and development ourselves; also deepen the industry ecology by extensional acquisition. |
Tel: |
13404212672 |
Mobile Phone: |
13404212672;18761920336 |
E-mail: |
vincent@realpharma.com.cn |
Web site: |
http://www.realpharma.com.cn |
Add: |
room 408,4th floor, building 8, area C, Dongfang Industrial Park, Suzhou Industrial Park, Suzhou City |
P.C.: |
215000 |